On November 21, 2023, Daniel R. Marshak, Ph.D., resigned from the Board of Directors of InVivo Therapeutics Holdings Corp., effective immediately. Dr. Marshak?s resignation was not the result of any disagreement with the Company or any matter relating to the Company?s operations, policies or practices.
InVivo Therapeutics Holdings Corp.
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | +2.78% | +2.78% | -49.32% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-49.32% | 1.15M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- NVIV Stock
- News InVivo Therapeutics Holdings Corp.
- Invivo Therapeutics Holdings Corp. Announces Resignation of Daniel R. Marshak from the Board of Directors